Archives

High-Protein Snacks for GLP-1 Users

You might recognize this scene. Lunch was small, you feel full sooner than usual, and by late afternoon you are both a little hungry and a little uninterested in a full plate. That’s a common GLP-1 experience. One trick is to keep a short list of satisfying, easy snacks that slip into your day and […]

The ‘magic’ medicine: Can weight-loss drug GLP-1 treat alcohol and drug addiction?

Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging research suggests these medications can dampen cravings for alcohol and drugs by influencing the brain’s reward system. While still in early stages, clinical trials and early patient experiences indicate a significant new therapeutic avenue for addiction treatment, offering hope […]

Healthcare, Vol. 13, Pages 2958: Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence

Healthcare, Vol. 13, Pages 2958: Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence Healthcare doi: 10.3390/healthcare13222958 Authors: Cristina Ștefănescu Elena Alexandra Bratu Ana Maria Pelin Denisa Boroi Bianca Daniela Crecan-Suciu Victorița Ștefănescu Objective: This is the first umbrella review to integrate the available research syntheses on the associations between glucagon-like peptide-1 […]

A case study on cravings and a GLP-1

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. As a reminder, STAT’s Isabella Cueto and J. Emory Parker are keeping track of every promise made by health secretary Robert F. Kennedy Jr. about reworking American health care. They just updated their tracker with […]

The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company

Eli Lilly shares have room to keep rising as GLP-1 drugs spread reach The trillion-dollar club has become crowded with mostly tech names riding the AI boom. Eli LillyLLY-0.35%decrease; red down pointing triangle might soon join them for a far different reason: the weight-loss bonanza. Crucially, …

The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum

For Immediate Release Chicago, IL – November 18, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly LLY, Johnson & Johnson JNJ and […]

Eli Lilly Drug Shows New Potential in Curbing Food Cravings

Eli Lilly Drug Shows New Potential in Curbing Food Cravings Eli Lilly and Company BATS:LLY DEXWireNews Eli Lilly’s GLP-1 weight-loss drug tirzepatide — sold as Mounjaro and Zepbound — may do more than suppress appetite. A new Nature Medicine report shows that in one patient with severe binge-eating behavior, the drug appeared to silence food-craving […]